NINLIB 200 mg NILOTINIB, used to treat Philadelphia chromosome –positive chronic myeloid leukemia (ph+ CML) , a type of blood cancer . it belongs to a class of drugs called tyrosine kinase inhibitor that block abnormal signals in cancer cells to stop them from growing. It function as tyrosine kinase inhibitors that target pathways of fibroblast proliferation and extracellular matrix deposition.
WHAT ARE NINLIBNINLIB 2OONINLIB 2OO MG CAPSULES?
NINLIB 200 mg is classified as an antineoplastic agent and a targeted protein kinase inhibitor , specifically a tyrosine kinase inhibitor (TKI) derived from a benzamide chemical structure . it contains the active pharmaceutical ingredient Nilotinib and is used in cancer care.
Key classification:
- Therapeutic class: Antineoplastic
- Action class: Tyrosine kinase inhibitor (TKI)
- Chemical class: Benzamide derivative
- Active ingredient: Nilotinib (200 mg strength )
- Mechanism of action: Disrupts the signaling route of the protein kinase enzyme which targets the BCR-ABL protein and inhibits the growth and spread of cancer cells .
WHAT ARE THE MEDICAL USES OF NINLIB 200 MG CAPSULE?
Medical uses of NINLIB 200 mg capsule are:
1)IODIOPATHIC PULMONARY FIBROSIS (IPF)
NINLIB 200 mg is a brand name associated with NINTEDANIB ,a tyrosine kinase inhibitor used to slow lung scarring in idiopathic pulmonary fibrosis (IPF) and progressive interstitial lung diseases. It works by blocking growth factor receptors that trigger tissue fibrosis.
- Slows disease progression
NINLIB 200 mg , which may be sold under various brand names ,is an antifibrotic medication approved to slow disease progression in idiopathic pulmonary fibrosis (IPF). It works as an tyrosine kinase inhibitor that blocks growth factor receptors, which helps slow the progression of lung scarring. It does not reverse existing lung damage ,but it reduces the annual rate of decline in forced vital capacity .
- Helps preserve lung function
NINLIB 200 mg helps preserve lung function by acting as an anti-fibrotic medication that slow the progression of lung tissue scarring . it is primarily prescribed for idiopathic pulmonary fibrosis (IPF) and progressive interstitial lung diseases (ILD). It function as a tyrosine kinase inhibitor ,blocking cell signals that trigger fibrosis and tissue thickening.
2)PROGRESSIVE PLUMONARY FIBROSIS (PPF)
NINLIB 200 mg is an anti-fibrotic medication used to help slow the worsening of lung scarring in progressive pulmonary fibrosis (PPF) . it works by blocking growth factor signals that cause lung tissue to scar, though it cannot repair existing damage. It slows down the yearly drop in lung function . it helps manage long-term disease progression under close specialist supervision.
- Treatment of chronic fibrosing interstitial lung diseases
The approved medication for chronic fibrosing interstitial lung disease (ILD) with a progressive phenotype is Nintedanib , it is formulated to addresses progressive lung fibrosis and works differently than oncology-focused targeted therapies.
- Reduces the decline in lung function
NINLIB 200 mg is an antifibrotic used to reduce the decline in lung function medication for patients with progressive scarring lung diseases. It blocks specific tyrosine kinase receptors that signals tissue to scar , helping to cut the speed of lung function decline by about half.
3)SYTEMATIC SCLEROSIS –ASSOCIATED INTERSTITIAL LUNG DISEASES (SSC-ILD)
NINLIB 200 mg is an antifibrotic medication used to reduce the decline in lung function for patients with progressive scarring lung diseases. It blocks specific tyrosine kinase receptors that signal tissue to scar, helping to cut the speed of lung function decline by about half.
- Helps manage lung fibrosis associated with systematic sclerosis
NINLIB 200 mg helps slows lung function decline in systemic sclerosis-associated interstitial lung disease . though the standard approved dose used in clinical trails is 150 mg taken orally twice daily ,rather than 200 mg. it slows down the active lung scarring or fibrosis , but it does not reverse existing damage or treat other extra-plumonary manifestations of systematic sclerosis .
HOW NINLIB 200 MG CAPSULES WORK?
NINLIB 200 mg capsule contains the active medicine nilotinib, which is a tyrosine kinase inhibitor (TKI) used to treat a type of blood cancer called Philadelphia chromosome –positive chronic myeloid leukemia (ph+ CML). It works by blocking abnormal chemical signals ,stopping cancer cells from multiplying , and causing the death of those bad cells . it works by the following ways:
- Mechanism of action of NINLIB
NINLIB 200 mg is a targeted cancer therapy belonging to the class of tyrosine kinase inhibitor . it works by binding to and locking the BCR-ABL fusion protein in an inactive shape, blocking ATP binding, and stopping the uncontrolled multiplication of leukemia cells.
- Inhibition of multiple tyrosine kinase receptors
NINLIB 200 mg is a targeted tyrosine kinase inhibitor (TKI) primarily used to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) . it specifically blocks the abnormal BCR-ABL tyrosine kinase protein produced by the Philadelphia chromosome ,stopping cancerous white blood cells from multiplying.
- Slowing of lung scarring progression
NINLIB 200 mg is an anti-fibrotic medication used to slow the worsening of lung scarring in conditions like idiopathic pulmonary fibrosis (IPF) and progressive interstitial lung diseases (ILD). It works by blocking specific cell signals that cause tissue scarring , thereby reducing the annual rate of decline in lung capacity. It acts by blocking receptors that cause fibroblast activation, proliferation, and migration which helps reduce lung tissue scarring and angiogenesis.
CONCLUSION
Preclinical studies suggest NINLIB 200 mg may reduce liver fibrosis progression by mitigating oxidative stress. However, as a targeted therapy ,it is not approved for liver disease and carries risks of severe liver injury.
FREQUENTLY ASKED QUESTIONS(FAQs):
QUESTION: WHAT ARE NINLIB 200 MG CAPSULES USED FOR?
NINLIB 200 mg is a prescription medicine used to treat Philadelphia chromosome –positive chronic myeloid leukemia (Ph+ CML) a type of blood cancer. It is prescribed for newly diagnosed patients and those who no longer respond to or cannot tolerate other treatments .
QUESTION: HOW DOES NINLIB WORK?
NINLIB is a targeted prescription medication containing nilotinib that treats a specific blood cancer called Philadelphia chromosome –positive chronic myeloid leukemia. It function as a tyrosine kinase inhibitor that blocks abnormal cellular signals and stops leukemia cells from multiplying.
QUESTION: CAN NINLIB 200 MG CAPSULES CURE PLUMONARY FIBROSIS?
No, NINLIB 200mg cannot cure pulmonary fibrosis. There is currently no definitive medical cure for pulmonary fibrosis, as existing scar tissue in the lungs cannot be reversed. However, depending on its specific active ingredient , NINLIB is used to manage the condition by slowing down disease progression.
REFRENCES:
1)https://www.macariushealth.com/products/oncology-cancer-care/ninlib-200mg-capsule/
2)https://drugcarts.com/product/ninlib-200mg-capsule?srsltid=AfmBOoqslFzpWXBQUbmWl12mxmE61_Fe-l21MVajEOrT3KKImdOPqVKg
